A recent study indicates that patients who stop using blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who halt conventional lifestyle plans.
Research printed in a leading medical journal demonstrates that while overweight people often shed substantial amounts of their body weight while undergoing treatment, the weight returns at an average rate of 0.8 kg per month once they quit.
"Users purchasing these drugs should be cognizant of the danger of fast weight regain when the treatment concludes," warns expert Dr. Susan Jebb.
That rate of regain suggests a return to starting weight in about a year and a half.
Analyzing Treatments
The analysis, which looked at 37 of studies involving thousands of patients, contrasted the outcomes of these new drugs with conventional dieting.
The team note that individuals who lose weight through lifestyle changes alone typically experience a slower weight regain—perhaps 0.1 kg a month—post-intervention.
Explaining the Quick Regain
Nutrition scientists suggest the way of the injections is key to understanding the heightened weight return.
GLP-1 drugs imitate a body's own chemical called GLP-1, which controls hunger.
"Artificially providing GLP-1 concentrations far above than normal may cause the system to generate a reduced amount of its own natural hormone, and could reduce responsiveness to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this medication leads to hunger is no longer kept in check, making excessive eating far more likely."
An Ongoing Condition?
Health authorities advise the jabs for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Professionals contend that, considering the high risk of relapse, the treatment might need to be life-long.
This view is supported by pharmaceutical companies, who state that the findings "highlight the persistent nature of excess weight," similar to managing diseases like hypertension.
User Accounts
Individuals who have stopped the jabs describe a intense resurgence of cravings.
"I experienced a trigger activating and you're instantly ravenous," recalled a patient.
This difficulty is exacerbated if individuals have not adopted permanent lifestyle or habit changes during therapy.
Growing Adoption
Recent estimates show that a significant number of people in the UK have tried these injections in the last 12 months, with desire being substantial.
- Adoption is more common among females compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the medications through private prescriptions rather than public health services.
Finally, clinicians stress that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent cure and lasting health benefits relies on combined lifestyle support.
